Last updated on 4 Apr 2023
Owner Info
Actinium Pharmaceuticals, Inc. incorporated in the State of Delaware
501 Fifth Avenue, 3rd Floor, New York,
New York, 10017,, UNITED STATES OF AMERICA
Serial Number
1517742 filed on 28 Sept 2012
Correspondent
Spruson & Ferguson
GPO Box 3898,
Sydney, NSW, 2001 AUSTRALIA,
1517742
28 Sept 2012
NA
WORD
4 Apr 2012
US
Status Date | Action Taken |
---|---|
4th Apr 2023 | IP Right Ceased correspondence sent |
4th Apr 2023 | Status change to Removed/Ceased - Not Renewed |
3rd Oct 2022 | Renewal Overdue correspondence sent |
28th Jul 2022 | Renewal Reminder correspondence sent |
30th May 2013 | IP Right Registration Published |
22nd May 2013 | Register Trade Mark |
22nd May 2013 | Application Status |
14th May 2013 | Registration fee (1 class) |
14th Feb 2013 | IP Right Acceptance Published |
8th Feb 2013 | Clear Examination report approved |